Mechanism
How Tiotropium works
Competitively blocks muscarinic receptors, especially M3 receptors, producing sustained inhibition of acetylcholine-mediated bronchoconstriction.
← Respiratory Pharmacology
LAMANBRC High Yield5/5 Importance
Tiotropium Respiratory Pharmacology Guide
Class, mechanism, indications, adverse effects, kinetics, exam traps, and NBRC-style study pearls.
Tiotropium is a long-acting muscarinic antagonist used mainly for maintenance bronchodilation in COPD. It blocks acetylcholine at airway muscarinic receptors and provides prolonged bronchodilation lasting about 24 hours. Its adverse effects are anticholinergic, especially dry mouth, urinary retention, constipation, and glaucoma-related caution. For exam questions, the key pearl is that tiotropium is maintenance therapy and should not be selected for immediate rescue of acute bronchospasm.
Clinical Pearl
What to remember
The NBRC trap is using tiotropium for acute distress; use SABA for rescue, LAMA for maintenance.
Kinetics
Onset, peak, and duration
1
Onset
About 30 minutes
2
Peak
1.5 to 3 hours
3
Duration
At least 24 hours
Quick facts
- Subclass
- LAMA
- NBRC importance
- 5/5
- Difficulty
- 2/5
- Brands
- Spiriva
Common indications
- Maintenance therapy for COPD
- Long-term bronchodilator therapy
- Add-on maintenance therapy in selected asthma patients
Adverse effects
- Dry mouth
- Constipation
- Urinary retention
- Blurred vision
- Glaucoma worsening
- Paradoxical bronchospasm
Contraindications
- Hypersensitivity to tiotropium, atropine derivatives, or formulation components
Cautions and safety issues
- Not for acute bronchospasm
- Use caution with narrow-angle glaucoma
- Use caution with urinary retention or prostatic hyperplasia
- Avoid powder or mist exposure to eyes
NBRC-style question
NBRC-style pharmacology review
A patient scenario involves stable copd patient needing maintenance bronchodilation. Which medication concept should the respiratory therapy student recognize?
High-yield answer
Tiotropium belongs to Long-Acting Muscarinic Antagonists.
Interactive practice
Practice in PharmaGenius
Master this medication through adaptive review of class, mechanism, indications, adverse effects, exam traps, and clinical scenarios. Missed concepts can later be surfaced for targeted remediation.
ClassPractice
MechanismPractice
Clinical usePractice
Adverse effectsPractice
ScenarioPractice
Common Exam Traps
These are the answer choices, mechanisms, or medication classes most commonly confused with this medication on RT school and NBRC-style exams.
- Short-acting beta agonist
- Short-acting muscarinic antagonist
- Inhaled corticosteroid
- Used for immediate rescue therapy
- Stimulates beta-2 receptors
High-Yield Clinical Scenarios
- Stable COPD patient needing maintenance bronchodilation
- COPD patient with persistent symptoms despite rescue inhaler
- Medication selection question where acute rescue therapy is not needed
Related study paths
Continue building pharmacology mastery
Use this medication page as a reference, then reinforce it with interactive practice and related PulmTools study resources.